Dynatronics Corporation(NASDAQ:DYNT) announced the earnings results for Fiscal Year 2016 and Q4. The results came in during Pre-market on Sep 26, 2016. Company reported revenue of $8.13M. Analysts estimated a revenue of $7.90M. Earnings per share were $-0.14. Analysts had estimated an EPS of $-0.14.
Dynatronics Corporation (DYNT) shares turned negative on Thursdays trading session with the shares closing down -0.04 points or -1.56% at a volume of 85,647. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $2.72. The peak price level was also seen at $2.72 while the days lowest was $2.4999. Finally the shares closed at $2.52. The 52-week high of the shares is $3.3599 while the 52-week low is $2.4. According to the latest information available, the market cap of the company is $7 M.
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications including therapy devices medical supplies and soft goods treatment tables and rehabilitation equipment. They are used by physical therapists chiropractors sports medicine practitioners podiatrists physicians and other physical medicine professionals. It markets a line of devices that include electrotherapy ultrasound or a combination of both of these modalities in a single device. The Company’s Dynatron Solaris Plus and Dynatron 25 Series include combination devices that provide electrotherapy and ultrasound therapy treatments to patients. It also distributes a line of iontophoresis electrodes under the brand name of Dynatron Ion electrodes along with other types of iontophoresis electrodes from other manufacturers. It sells products manufactured by others as well as its own product lines.